Invasive staging of non-small cell lung cancer--a prospective study

Area of Science:

• Oncology
• Thoracic Surgery
• Diagnostic Imaging

Background:

• Non-small cell lung cancer (NSCLC) prognosis and treatment depend heavily on accurate tumor staging.
• Precise pretreatment staging of primary tumors and lymph nodes is vital for differentiating resectable from non-resectable locally advanced NSCLC.
• Mediastinoscopy is recognized for superior lymph node assessment in the upper mediastinum compared to radiological methods, though thoracoscopy is less established.

Purpose of the Study:

• To evaluate the diagnostic value of mediastinoscopy and thoracoscopy in staging locally advanced non-small cell lung cancer (NSCLC).
• To compare the accuracy of invasive staging methods with radiological findings in NSCLC patients.
• To determine the impact of accurate staging on therapeutic planning and patient outcomes.

Main Methods:

• A phase II study involving 73 consecutive patients with CT-assessed advanced NSCLC.
• All patients underwent mediastinoscopy and mediastinal lymph node sampling.
• Thoracoscopy was performed in cases with negative mediastinoscopy results.

Main Results:

• Invasive staging altered radiological findings in 52.1% of patients.
• Mediastinoscopy identified unexpected positive lymph nodes in 12.3% and negative nodes in 15.1% of cases.
• Thoracoscopy revealed unexpected T4 or M1 stages in 11% and excluded suspected infiltration in 9.6% of patients, with 17.8% overstaged and 16.4% understaged by initial radiological assessment.

Conclusions:

• Radiological methods alone are insufficient for diagnosing stage III NSCLC, leading to incorrect classification in approximately 34% of cases.
• Mediastinoscopy combined with thoracoscopy is essential for accurate therapeutic planning in locally advanced NSCLC.
• Invasive staging procedures offer significantly superior diagnostic accuracy compared to clinical staging alone.